A pair of Hogan Lovells life sciences partners, including a group leader, are joining Paul Hastings to build the firm’s regulatory bench for pharmaceutical and biotech clients.
Lynn Mehler, a former senior attorney in the Food and Drug Administration who co-headed the life sciences group at Hogan Lovells, will oversee the life sciences regulatory practice at Paul Hastings as its first chair. Leaders are looking to her to tap into demand among the firm’s life sciences clients for regulatory advice.
“There are a number of clients they work with who they want to work with more deeply,” Mehler said. “This ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.